These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34907233)

  • 1. Postoperative proliferative vitreoretinopathy development is linked to vitreal CXCL5 concentrations.
    Zandi S; Pfister IB; Garweg JG
    Sci Rep; 2021 Dec; 11(1):23989. PubMed ID: 34907233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers for PVR in rhegmatogenous retinal detachment.
    Zandi S; Pfister IB; Traine PG; Tappeiner C; Despont A; Rieben R; Skowronska M; Garweg JG
    PLoS One; 2019; 14(4):e0214674. PubMed ID: 30943234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CONCENTRATIONS OF VITREAL CYTOKINES IN RHEGMATOGENOUS RETINAL DETACHMENT.
    Danielescu C; Zugun-Eloae F; Zlei M
    Rev Med Chir Soc Med Nat Iasi; 2016; 120(1):124-9. PubMed ID: 27125084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Position of macula lutea and presence of proliferative vitreoretinopathy affect vitreous cytokine expression in rhegmatogenous retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Resch MD
    PLoS One; 2020; 15(6):e0234525. PubMed ID: 32542038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological biomarkers of the vitreous responsible for proliferative alteration in the different forms of retinal detachment.
    Balogh A; Milibák T; Szabó V; Nagy ZZ; Kaarniranta K; Resch MD
    BMC Ophthalmol; 2020 Dec; 20(1):491. PubMed ID: 33371882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokine levels in subretinal fluid obtained during scleral buckling surgery after rhegmatogenous retinal detachment.
    Ricker LJ; Kijlstra A; de Jager W; Liem AT; Hendrikse F; La Heij EC
    Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4143-50. PubMed ID: 20335622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokine profiles of phakic and pseudophakic eyes with primary retinal detachment.
    Garweg JG; Zandi S; Pfister I; Rieben R; Skowronska M; Tappeiner C
    Acta Ophthalmol; 2019 Jun; 97(4):e580-e588. PubMed ID: 30561135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
    Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA
    Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651
    [No Abstract]   [Full Text] [Related]  

  • 10. Levels of some cytokines in subretinal fluid in proliferative vitreoretinopathy and rhegmatogenous retinal detachment.
    Kenarova B; Voinov L; Apostolov C; Vladimirova R; Misheva A
    Eur J Ophthalmol; 1997; 7(1):64-7. PubMed ID: 9101198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
    Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
    Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
    Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
    Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
    Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
    Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
    Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
    Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative vitreous hemorrhage associated with rhegmatogenous retinal detachment: a risk factor for postoperative proliferative vitreoretinopathy?
    Duquesne N; Bonnet M; Adeleine P
    Graefes Arch Clin Exp Ophthalmol; 1996 Nov; 234(11):677-82. PubMed ID: 8950587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of vitreous cytokines in proliferative vitreoretinopathy: a prospective study.
    Kon CH; Occleston NL; Aylward GW; Khaw PT
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):705-12. PubMed ID: 10067974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of transforming growth factor β-1 vitreous levels with clinical severity of proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
    Palomares-Ordóñez JL; Sánchez-Ramos JA; Ramírez-Estudillo JA; Robles-Contreras A
    Arch Soc Esp Oftalmol (Engl Ed); 2019 Jan; 94(1):12-17. PubMed ID: 30309666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous levels of Lipocalin-2 on patients with primary rhegmatogenous retinal detachment.
    Batsos G; Christodoulou E; Vartholomatos G; Galanis P; Stefaniotou M
    PLoS One; 2019; 14(12):e0227266. PubMed ID: 31891637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.